Oncology Learning Network

Evolution of the treatment landscape for Tenosynovial Giant Cell Tumors 21.11.2019 3:43 ↓

Jonathan Trent, MD, PhD, Professor and Associate Director for Clinical Research, Sylvester Comprehensive Cancer Center, University of Miami, Florida discusses the evolution of the current treatment landscape for tenosynovial giant cell tumors.

Pexidartinib Demonstrates Great Tumor Response in Tenosynovial Giant Cell Tumors 08.11.2019 5:19 ↓

Pexidartinib Demonstrates Great Tumor Response in Tenosynovial Giant Cell Tumors by HMP Global

Niraparib After First-Line Chemotherapy New Standard of Care for Advanced Ovarian Cancer 29.10.2019 5:31 ↓

Niraparib After First-Line Chemotherapy New Standard of Care for Advanced Ovarian Cancer by HMP Global

Amer Zeidan, MBBS, MHS, discusses Myelodysplastic Syndrome(MDS)at 2019 ASH MHM 24.10.2019 16:41 ↓

Amer Zeidan, MBBS, MHS, Yale University, discusses diagnosis and treatment of Myelodysplastic Syndrome(MDS)at 2019 ASH Meeting on Hematologic Malignancies

Newer Treatment Options for Patients With Hodgkin Lymphoma 18.10.2019 5:55 ↓

Newer Treatment Options for Patients With Hodgkin Lymphoma by HMP Global

Treating Newly Diagnosed Patients With MCL 17.10.2019 8:32 ↓

Treating Newly Diagnosed Patients With MCL by HMP Global

FOxTROT Trial Supports Preoperative Chemotherapy in Colon Cancer, with Matthew Seymour, MD 01.10.2019 19:17 ↓

Matthew Seymour, MD, discusses the FOxTROT trial that supports preoperative chemotherapy as a treatment with multiple, clear benefits for patients with colon cancer.

Isatuximab Triplet Encouraging for Relapsed/Refractory Multiple Myeloma 12.09.2019 9:32 ↓

Isatuximab Triplet Encouraging for Relapsed/Refractory Multiple Myeloma by HMP Global

Neratinib Plus Capecitabine Improves PFS in HER2-Positive Breast Cancer 31.07.2019 5:15 ↓

Neratinib Plus Capecitabine Improves PFS in HER2-Positive Breast Cancer by HMP Global

Adding Ribociclib to Endocrine Therapy Improves OS in Young Patients With Advanced Breast Cancer 19.06.2019 6:20 ↓

Sara A. Hurvitz, MD, University of California-Los Angeles Jonsson Comprehensive Cancer Center, discusses the background, findings, and clinical significance of the MONALEESA 7 trial, the findings of which were presented at the 2019 ASCO Annual Meeting.

Ixazomib Promising Maintenance Therapy Option for Multiple Myeloma 11.04.2019 2:02 ↓

Ixazomib Promising Maintenance Therapy Option for Multiple Myeloma by HMP Global

Novel Immunotherapy Approaches for Multiple Myeloma 11.04.2019 7:21 ↓

Novel Immunotherapy Approaches for Multiple Myeloma by HMP Global

Earlier Daratumamab Use Feasible for Relapsed/Refractory Multiple Myeloma 11.04.2019 7:21 ↓

Earlier Daratumamab Use Feasible for Relapsed/Refractory Multiple Myeloma by HMP Global

Survey Results Show Oncologists Want to Learn More About the Needs of LGBTQ Patients 04.04.2019 10:34 ↓

Matthew B. Schabath, PhD, discusses the results of his team’s national survey, which was conducted to identify potential gaps in attitudes, knowledge, and institutional practices toward LGBTQ patients with cancer.

Daunorubicin Decreases Long-Term Cardiomyopathy Risk in Childhood Cancer Survivors 12.03.2019 10:58 ↓

Daunorubicin Decreases Long-Term Cardiomyopathy Risk in Childhood Cancer Survivors by HMP Global

Patient Characteristics to Consider for Use of Chemotherapy for Soft-Tissue Sarcoma 06.03.2019 1:02 ↓

Patient Characteristics to Consider for Use of Chemotherapy for Soft-Tissue Sarcoma by HMP Global

Are Existing Data Reliable Enough to Support Using Chemo for Soft-Tissue Sarcoma? 26.02.2019 1:18 ↓

Are Existing Data Reliable Enough to Support Using Chemo for Soft-Tissue Sarcoma? by HMP Global

Enzalutamide–ADT Combo significantly Improves PFS in Metastatic Hormone-Sensitive Prostate Cancer 26.02.2019 7:49 ↓

Enzalutamide–ADT Combo significantly Improves PFS in Metastatic Hormone-Sensitive Prostate Cancer by HMP Global

“Spectacular” Trial Results Establish New Standard of Care for Advanced Kidney Cancer 21.02.2019 2:24 ↓

“Spectacular” Trial Results Establish New Standard of Care for Advanced Kidney Cancer by HMP Global

Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC 21.02.2019 3:47 ↓

Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC by HMP Global

Survival Benefits of PARP Inhibitors in Metastatic CRPC Favor BRCA1/2 Over ATM Mutations 21.02.2019 4:18 ↓

Survival Benefits of PARP Inhibitors in Metastatic CRPC Favor BRCA1/2 Over ATM Mutations by HMP Global

Great Debates in Oncology: Preview of Round 1 - Dr Trent 20.02.2019 1:26 ↓

Great Debates in Oncology: Preview of Round 1 - Dr Trent by HMP Global

Practice-Changing Potential in CLL 19.02.2019 2:57 ↓

Practice-Changing Potential in CLL by HMP Global

Apalutamide Significantly Delays Metastasis in SPARTAN Trial of Nonmetastatic CRPC 14.02.2019 8:46 ↓

Apalutamide Significantly Delays Metastasis in SPARTAN Trial of Nonmetastatic CRPC by HMP Global

New Advances in Research Pave the Way for the Treatment of Nonclear Cell RCC 14.02.2019 9:09 ↓

New Advances in Research Pave the Way for the Treatment of Nonclear Cell RCC by HMP Global